The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
iShares Paris-Aligned ClmMSCIWldExUSAETF PABD
Morningstar’s Analysis PABD
Will PABD outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 13.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 2.06 | 1.1 Mil | Healthcare |
ASML Holding NV | 1.99 | 1.1 Mil | Technology |
Schneider Electric SE | 1.37 | 735,912 | Industrials |
Novartis AG Registered Shares | 1.31 | 706,151 | Healthcare |
SAP SE | 1.28 | 690,765 | Technology |
AstraZeneca PLC | 1.27 | 683,763 | Healthcare |
Roche Holding AG | 1.23 | 659,434 | Healthcare |
ABB Ltd | 1.13 | 605,207 | Industrials |
Royal Bank of Canada | 1.12 | 602,400 | Financial Services |
Lvmh Moet Hennessy Louis Vuitton SE | 1.10 | 590,117 | Consumer Cyclical |